UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) 
of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): June 10, 2020

 

 

Atreca, Inc.

(Exact name of Registrant as Specified in Its Charter)

 

 

 

 

(650) 595-2595

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

o                     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o                     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o                     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o                     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

 

 

 

Item 5.07                      Submission of Matters to a Vote of Security Holders.

 

The proposals set forth below were submitted to the stockholders at the 2020 Annual Meeting of Stockholders (the “Annual Meeting”) of Atreca, Inc. (the “Company”) held on June 10, 2020.  Each such proposal was described in the Company’s definitive proxy statement for the Annual Meeting filed with the U.S. Securities and Exchange Commission on April 29, 2020 (the “Proxy Statement”).

 

There were 22,153,387 shares of the Company’s Class A common stock entitled to vote at the Annual Meeting.  There were 17,828,495 shares of the Company’s Class A common stock present or represented by valid proxy at the Annual Meeting.  The number of votes cast for and against, and the number of abstentions and broker non-votes, with respect to each proposal voted upon are set forth below.

 

Proposal 1 — Election of Directors

 

The Company’s stockholders elected the Class I director nominees below to the Company’s Board of Directors to hold office until the 2023 Annual Meeting of Stockholders or until their successors are duly elected and qualified.

 

Class I Director Nominee		Votes For		Votes Withheld
David Lacey, M.D.		14,178,350		1,963,483
Lindsey Rolfe, MBChB		16,066,417		75,416

 

There were 1,686,662 broker non-votes for Proposal 1.

 

Proposal 2 — Ratification of Appointment of Independent Registered Accounting Firm

 

The Company’s stockholders ratified the appointment of OUM & Co. LLP as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2020.

 

Votes For		Votes Against		Abstentions
17,817,205		3,111		8,179

 

There were no broker non-votes for Proposal 2.

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

		Atreca, Inc.
Dated: June 16, 2020		By:	/s/ Courtney J. Phillips
			Courtney J. Phillips
			General Counsel and Corporate Secretary

 

3